本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Merrimack Pharmaceuticals

15.13
0.0000
成交量:- -
成交額:- -
市值:2.24億
市盈率:1.08
高:15.13
開:15.13
低:15.13
收:15.13
52周最高:15.13
52周最低:15.13
股本:1,478.84萬
流通股本:957.29萬
量比:- -
換手率:- -
股息:2
股息率:13.22%
每股收益(TTM):13.97
每股收益(LYR):-0.0826
淨資產收益率:-1.12%
總資產收益率:-1.07%
市淨率:1.01
市盈率(LYR):-183.19

資料載入中...

2020/07/27

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/07/24

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/28

重要事件披露

8-K - Current report
2020/05/07

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/03/30

重要事件披露

Current report, items 1.01, 2.01, and 9.01
2020/03/13

員工持股計劃

Securities to be offered to employees in employee benefit plans
2020/03/12

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/21

重要事件披露

Current report, item 5.08
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/12/03

重要事件披露

Current report, items 1.01, 3.03, 5.03, and 9.01
2019/11/19

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/11/12

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/10/21

重要事件披露

Current report, item 5.07
2019/09/30

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/09/30

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/09/26

SEC問詢函

[Cover]Correspondence
2019/09/24

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/09/20

重要事件披露

Current report, items 1.01, 5.02, and 9.01